BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Antoni L, Nuding S, Wehkamp J, Stange EF. Intestinal barrier in inflammatory bowel disease. World J Gastroenterol 2014; 20(5): 1165-1179 [PMID: 24574793 DOI: 10.3748/wjg.v20.i5.1165] [Cited by in CrossRef: 169] [Cited by in F6Publishing: 149] [Article Influence: 24.1] [Reference Citation Analysis]
Number Citing Articles
1 Lee J, Park EJ, Yuki Y, Ahmad S, Mizuguchi K, Ishii KJ, Shimaoka M, Kiyono H. Profiles of microRNA networks in intestinal epithelial cells in a mouse model of colitis. Sci Rep 2015;5:18174. [PMID: 26647826 DOI: 10.1038/srep18174] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
2 Lee JY, Wasinger VC, Yau YY, Chuang E, Yajnik V, Leong RW. Molecular Pathophysiology of Epithelial Barrier Dysfunction in Inflammatory Bowel Diseases. Proteomes 2018;6:E17. [PMID: 29614738 DOI: 10.3390/proteomes6020017] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
3 Chiodini RJ, Dowd SE, Galandiuk S, Davis B, Glassing A. The predominant site of bacterial translocation across the intestinal mucosal barrier occurs at the advancing disease margin in Crohn's disease. Microbiology (Reading) 2016;162:1608-19. [PMID: 27418066 DOI: 10.1099/mic.0.000336] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
4 Lemmens G, Van Camp A, Kourula S, Vanuytsel T, Augustijns P. Drug Disposition in the Lower Gastrointestinal Tract: Targeting and Monitoring. Pharmaceutics 2021;13:161. [PMID: 33530468 DOI: 10.3390/pharmaceutics13020161] [Reference Citation Analysis]
5 Xu P, Elizalde M, Masclee A, Pierik M, Jonkers D. Corticosteroid enhances epithelial barrier function in intestinal organoids derived from patients with Crohn's disease. J Mol Med (Berl) 2021;99:805-15. [PMID: 33575854 DOI: 10.1007/s00109-021-02045-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bilski J, Mazur-Bialy A, Wojcik D, Zahradnik-Bilska J, Brzozowski B, Magierowski M, Mach T, Magierowska K, Brzozowski T. The Role of Intestinal Alkaline Phosphatase in Inflammatory Disorders of Gastrointestinal Tract. Mediators Inflamm 2017;2017:9074601. [PMID: 28316376 DOI: 10.1155/2017/9074601] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 15.3] [Reference Citation Analysis]
7 Basil M, Schwartz D, Dalal R, Horst S, Scoville E, Adams D, Beaulieu D, Slaughter JC, Higginbotham T, Vaezi M, Choksi Y. Mucosal Integrity Testing Can Detect Differences in the Rectums of Patients with Inflammatory Bowel Disease Compared to Controls: A Pilot Study. Dig Dis Sci 2021. [PMID: 33638748 DOI: 10.1007/s10620-021-06888-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zolotova NA, Polikarpova AV, Khochanskii DN, Makarova OV, Mikhailova LP. Expression of Mucins and Claudins in the Colon during Acute and Chronic Experimental Colitis. Bull Exp Biol Med 2018;165:434-7. [PMID: 30123951 DOI: 10.1007/s10517-018-4187-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Loktionov A. Eosinophils in the gastrointestinal tract and their role in the pathogenesis of major colorectal disorders. World J Gastroenterol 2019; 25(27): 3503-3526 [PMID: 31367153 DOI: 10.3748/wjg.v25.i27.3503] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 23] [Article Influence: 15.5] [Reference Citation Analysis]
10 Hua S. Physiological and Pharmaceutical Considerations for Rectal Drug Formulations. Front Pharmacol 2019;10:1196. [PMID: 31680970 DOI: 10.3389/fphar.2019.01196] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
11 Xiang C, Liu M, Lu Q, Fan C, Lu H, Feng C, Yang X, Li H, Tang W. Blockade of TLRs-triggered macrophage activation by caffeic acid exerted protective effects on experimental ulcerative colitis. Cell Immunol 2021;365:104364. [PMID: 33932876 DOI: 10.1016/j.cellimm.2021.104364] [Reference Citation Analysis]
12 Xu P, Becker H, Elizalde M, Pierik M, Masclee A, Jonkers D. Interleukin-28A induces epithelial barrier dysfunction in CD patient-derived intestinal organoids. Am J Physiol Gastrointest Liver Physiol 2021;320:G689-99. [PMID: 33595362 DOI: 10.1152/ajpgi.00064.2020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ward JBJ, Lajczak NK, Kelly OB, O'Dwyer AM, Giddam AK, Ní Gabhann J, Franco P, Tambuwala MM, Jefferies CA, Keely S, Roda A, Keely SJ. Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon. Am J Physiol Gastrointest Liver Physiol 2017;312:G550-8. [PMID: 28360029 DOI: 10.1152/ajpgi.00256.2016] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 14.5] [Reference Citation Analysis]
14 Cukrowska B, Sowińska A, Bierła JB, Czarnowska E, Rybak A, Grzybowska-Chlebowczyk U. Intestinal epithelium, intraepithelial lymphocytes and the gut microbiota - Key players in the pathogenesis of celiac disease. World J Gastroenterol 2017; 23(42): 7505-7518 [PMID: 29204051 DOI: 10.3748/wjg.v23.i42.7505] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 38] [Article Influence: 10.8] [Reference Citation Analysis]
15 Li H, Fan C, Lu H, Feng C, He P, Yang X, Xiang C, Zuo J, Tang W. Protective role of berberine on ulcerative colitis through modulating enteric glial cells-intestinal epithelial cells-immune cells interactions. Acta Pharm Sin B 2020;10:447-61. [PMID: 32140391 DOI: 10.1016/j.apsb.2019.08.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 11.0] [Reference Citation Analysis]
16 Huang Y, Wang Z, Li J, Bai S, Shen B, Du J, Xia X, Wang F. The effect of serine phosphorylated claudin-7 on the epithelial barrier and the modulation by transient receptor potential vanilloid 4 in human colonic cells. Biomedicine & Pharmacotherapy 2018;108:540-6. [DOI: 10.1016/j.biopha.2018.09.070] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
17 Ruan Z, Mi S, Zhou L, Zhou Y, Li J, Liu W, Deng Z, Yin Y. Chlorogenic acid enhances intestinal barrier by decreasing MLCK expression and promoting dynamic distribution of tight junction proteins in colitic rats. Journal of Functional Foods 2016;26:698-708. [DOI: 10.1016/j.jff.2016.08.038] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 4.4] [Reference Citation Analysis]
18 Hu M, Fang C, Liu Y, Gao M, Zhang D, Shi G, Yin Z, Zheng R, Zhang J. Comparative study of the laxative effects of konjac oligosaccharides and konjac glucomannan on loperamide-induced constipation in rats. Food Funct 2021;12:7709-17. [PMID: 34286775 DOI: 10.1039/d1fo01237a] [Reference Citation Analysis]
19 Zhao Q, Liu Y, Tan L, Yan L, Zuo X. Adiponectin administration alleviates DSS-induced colonic inflammation in Caco-2 cells and mice. Inflamm Res 2018;67:663-70. [PMID: 29766204 DOI: 10.1007/s00011-018-1155-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
20 Chen F, Liu Q, Xiong Y, Xu L. Current Strategies and Potential Prospects of Nanomedicine-Mediated Therapy in Inflammatory Bowel Disease. Int J Nanomedicine 2021;16:4225-37. [PMID: 34188471 DOI: 10.2147/IJN.S310952] [Reference Citation Analysis]
21 Xiao Y, Zhou Y, Sun S, Wang H, Wu S, Bao W. Effect of Promoter Methylation on the Expression of Porcine MUC2 Gene and Resistance to PEDV Infection. Front Vet Sci 2021;8:646408. [PMID: 33996974 DOI: 10.3389/fvets.2021.646408] [Reference Citation Analysis]
22 Richardson L, Vargas G, Brown T, Ochoa L, Trivedi J, Kacerovský M, Lappas M, Menon R. Redefining 3Dimensional placental membrane microarchitecture using multiphoton microscopy and optical clearing. Placenta 2017;53:66-75. [PMID: 28487023 DOI: 10.1016/j.placenta.2017.03.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
23 Rogler G. Resolution of inflammation in inflammatory bowel disease. Lancet Gastroenterol Hepatol 2017;2:521-30. [PMID: 28606878 DOI: 10.1016/S2468-1253(17)30031-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
24 Mroz MS, Lajczak NK, Goggins BJ, Keely S, Keely SJ. The bile acids, deoxycholic acid and ursodeoxycholic acid, regulate colonic epithelial wound healing. Am J Physiol Gastrointest Liver Physiol. 2018;314:G378-G387. [PMID: 29351391 DOI: 10.1152/ajpgi.00435.2016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
25 Gómez DP, Boudreau F. Organoids and Their Use in Modeling Gut Epithelial Cell Lineage Differentiation and Barrier Properties During Intestinal Diseases. Front Cell Dev Biol 2021;9:732137. [PMID: 34485312 DOI: 10.3389/fcell.2021.732137] [Reference Citation Analysis]
26 Xu Y, Xie L, Zhang Z, Zhang W, Tang J, He X, Zhou J, Peng W. Tremella fuciformis Polysaccharides Inhibited Colonic Inflammation in Dextran Sulfate Sodium-Treated Mice via Foxp3+ T Cells, Gut Microbiota, and Bacterial Metabolites. Front Immunol 2021;12:648162. [PMID: 33868283 DOI: 10.3389/fimmu.2021.648162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Robinson K, Deng Z, Hou Y, Zhang G. Regulation of the Intestinal Barrier Function by Host Defense Peptides. Front Vet Sci 2015;2:57. [PMID: 26664984 DOI: 10.3389/fvets.2015.00057] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 9.2] [Reference Citation Analysis]
28 Hegyi P, Maléth J, Walters JR, Hofmann AF, Keely SJ. Guts and Gall: Bile Acids in Regulation of Intestinal Epithelial Function in Health and Disease. Physiol Rev 2018;98:1983-2023. [PMID: 30067158 DOI: 10.1152/physrev.00054.2017] [Cited by in Crossref: 81] [Cited by in F6Publishing: 74] [Article Influence: 40.5] [Reference Citation Analysis]
29 Lian P, Braber S, Garssen J, Wichers HJ, Folkerts G, Fink-Gremmels J, Varasteh S. Beyond Heat Stress: Intestinal Integrity Disruption and Mechanism-Based Intervention Strategies. Nutrients 2020;12:E734. [PMID: 32168808 DOI: 10.3390/nu12030734] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 18.0] [Reference Citation Analysis]
30 Mao X, Qiu X, Jiao C, Lu M, Zhao X, Li X, Li J, Ma J, Zhang H. Candida albicans SC5314 inhibits NLRP3/NLRP6 inflammasome expression and dampens human intestinal barrier activity in Caco-2 cell monolayer model. Cytokine 2020;126:154882. [PMID: 31629100 DOI: 10.1016/j.cyto.2019.154882] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
31 Zheng JD, He Y, Yu HY, Liu YL, Ge YX, Li XT, Li X, Wang Y, Guo MR, Qu YL, Qin XF, Jiang MS, Wang XH. Unconjugated bilirubin alleviates experimental ulcerative colitis by regulating intestinal barrier function and immune inflammation. World J Gastroenterol 2019; 25(15): 1865-1878 [PMID: 31057300 DOI: 10.3748/wjg.v25.i15.1865] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
32 Alexander DB, Iigo M, Abdelgied M, Ozeki K, Tanida S, Joh T, Takahashi S, Tsuda H. Bovine lactoferrin and Crohn's disease: a case study. Biochem Cell Biol 2017;95:133-41. [PMID: 28165294 DOI: 10.1139/bcb-2016-0107] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
33 Perna A, Hay E, Contieri M, De Luca A, Guerra G, Lucariello A. Adherent-invasive Escherichia coli (AIEC): Cause or consequence of inflammation, dysbiosis, and rupture of cellular joints in patients with IBD? J Cell Physiol 2020;235:5041-9. [PMID: 31898324 DOI: 10.1002/jcp.29430] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
34 Manuc TE, Manuc MM, Diculescu MM. Recent insights into the molecular pathogenesis of Crohn's disease: a review of emerging therapeutic targets. Clin Exp Gastroenterol 2016;9:59-70. [PMID: 27042137 DOI: 10.2147/CEG.S53381] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
35 Formiga RO, Alves Júnior EB, Vasconcelos RC, Guerra GCB, Antunes de Araújo A, Carvalho TG, Garcia VB, de Araújo Junior RF, Gadelha FAAF, Vieira GC, Sobral MV, Barbosa Filho JM, Spiller F, Batista LM. p-Cymene and Rosmarinic Acid Ameliorate TNBS-Induced Intestinal Inflammation Upkeeping ZO-1 and MUC-2: Role of Antioxidant System and Immunomodulation. Int J Mol Sci 2020;21:E5870. [PMID: 32824269 DOI: 10.3390/ijms21165870] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
36 Patel MM. Micro/nano-particulate drug delivery systems: a boon for the treatment of inflammatory bowel disease. Expert Opinion on Drug Delivery 2016;13:771-5. [DOI: 10.1517/17425247.2016.1166203] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
37 Tokuhara D, Kurashima Y, Kamioka M, Nakayama T, Ernst P, Kiyono H. A comprehensive understanding of the gut mucosal immune system in allergic inflammation. Allergology International 2019;68:17-25. [DOI: 10.1016/j.alit.2018.09.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
38 Gong Y, Niu W, Tang Y, Zhang Q, Liu S, Liu X, Wang X, Xu Y. Aggravated mucosal and immune damage in a mouse model of ulcerative colitis with stress. Exp Ther Med 2019;17:2341-8. [PMID: 30783488 DOI: 10.3892/etm.2019.7162] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
39 Dorier M, Béal D, Tisseyre C, Marie-desvergne C, Dubosson M, Barreau F, Houdeau E, Herlin-boime N, Rabilloud T, Carriere M. The food additive E171 and titanium dioxide nanoparticles indirectly alter the homeostasis of human intestinal epithelial cells in vitro. Environ Sci : Nano 2019;6:1549-61. [DOI: 10.1039/c8en01188e] [Cited by in Crossref: 21] [Article Influence: 10.5] [Reference Citation Analysis]
40 Chen S, Li X, Li M, Mei Q, Huang J, Wu Z, Zhang L. Mucosal expression of defensin-5, soluble phospholipase A2 and lysozyme in the intestine in a rat model of acute liver failure and its relationship to intestinal bacterial translocation. Gastroenterol Hepatol 2020;43:293-300. [PMID: 32278502 DOI: 10.1016/j.gastrohep.2020.01.004] [Reference Citation Analysis]
41 Jing W, Dong S, Luo X, Liu J, Wei B, Du W, Yang L, Luo H, Wang Y, Wang S, Lu H. Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites. Pharmacol Res 2021;164:105358. [PMID: 33285228 DOI: 10.1016/j.phrs.2020.105358] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
42 Nivoliez A, Veisseire P, Alaterre E, Dausset C, Baptiste F, Camarès O, Paquet-Gachinat M, Bonnet M, Forestier C, Bornes S. Influence of manufacturing processes on cell surface properties of probiotic strain Lactobacillus rhamnosus Lcr35®. Appl Microbiol Biotechnol 2015;99:399-411. [PMID: 25280746 DOI: 10.1007/s00253-014-6110-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
43 Jacob EM, Borah A, Pillai SC, Kumar DS. Inflammatory Bowel Disease: The Emergence of New Trends in Lifestyle and Nanomedicine as the Modern Tool for Pharmacotherapy. Nanomaterials (Basel) 2020;10:E2460. [PMID: 33316984 DOI: 10.3390/nano10122460] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
44 Krumbeck JA, Rasmussen HE, Hutkins RW, Clarke J, Shawron K, Keshavarzian A, Walter J. Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics. Microbiome 2018;6:121. [PMID: 29954454 DOI: 10.1186/s40168-018-0494-4] [Cited by in Crossref: 77] [Cited by in F6Publishing: 70] [Article Influence: 25.7] [Reference Citation Analysis]
45 Schmitt H, Neufert C, Neurath MF, Atreya R. Resolution of Crohn's disease. Semin Immunopathol 2019;41:737-46. [PMID: 31552470 DOI: 10.1007/s00281-019-00756-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
46 Tanaka H, Gunasekaran S, Saleh DM, Alexander WT, Alexander DB, Ohara H, Tsuda H. Effects of oral bovine lactoferrin on a mouse model of inflammation associated colon cancer. Biochem Cell Biol 2021;99:159-65. [PMID: 32905707 DOI: 10.1139/bcb-2020-0087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
47 Akhtar AA, Sances S, Barrett R, Breunig JJ. Organoid and Organ-on-a-Chip Systems: New Paradigms for Modeling Neurological and Gastrointestinal Disease. Curr Stem Cell Rep 2017;3:98-111. [DOI: 10.1007/s40778-017-0080-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
48 Kelly JR, Kennedy PJ, Cryan JF, Dinan TG, Clarke G, Hyland NP. Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front Cell Neurosci. 2015;9:392. [PMID: 26528128 DOI: 10.3389/fncel.2015.00392] [Cited by in Crossref: 366] [Cited by in F6Publishing: 364] [Article Influence: 61.0] [Reference Citation Analysis]
49 Cai R, Cheng C, Chen J, Xu X, Ding C, Gu B. Interactions of commensal and pathogenic microorganisms with the mucus layer in the colon. Gut Microbes 2020;11:680-90. [PMID: 32223365 DOI: 10.1080/19490976.2020.1735606] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
50 Uluçkan Ö, Wagner EF. Chronic systemic inflammation originating from epithelial tissues. FEBS J 2017;284:505-16. [DOI: 10.1111/febs.13904] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
51 Palmela C, Chevarin C, Xu Z, Torres J, Sevrin G, Hirten R, Barnich N, Ng SC, Colombel JF. Adherent-invasive Escherichia coli in inflammatory bowel disease. Gut. 2018;67:574-587. [PMID: 29141957 DOI: 10.1136/gutjnl-2017-314903] [Cited by in Crossref: 149] [Cited by in F6Publishing: 142] [Article Influence: 37.3] [Reference Citation Analysis]
52 Ferrari D, Cimino F, Fratantonio D, Molonia MS, Bashllari R, Busà R, Saija A, Speciale A. Cyanidin-3-O-Glucoside Modulates the In Vitro Inflammatory Crosstalk between Intestinal Epithelial and Endothelial Cells. Mediators Inflamm 2017;2017:3454023. [PMID: 28373746 DOI: 10.1155/2017/3454023] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 7.8] [Reference Citation Analysis]
53 Bloemendaal AL, Buchs NC, George BD, Guy RJ. Intestinal stem cells and intestinal homeostasis in health and in inflammation: A review. Surgery 2016;159:1237-48. [PMID: 26936524 DOI: 10.1016/j.surg.2016.01.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
54 Ibarra-Coronado EG, Pérez-Torres A, Pantaleón-Martínez AM, Velazquéz-Moctezuma J, Rodriguez-Mata V, Morales-Montor J. Innate immunity modulation in the duodenal mucosa induced by REM sleep deprivation during infection with Trichinella spirallis. Sci Rep 2017;7:45528. [PMID: 28374797 DOI: 10.1038/srep45528] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
55 Shastri S, Shinde T, Perera AP, Gueven N, Eri R. Idebenone Protects against Spontaneous Chronic Murine Colitis by Alleviating Endoplasmic Reticulum Stress and Inflammatory Response. Biomedicines 2020;8:E384. [PMID: 32998266 DOI: 10.3390/biomedicines8100384] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
56 Biedermann L, Rogler G. The intestinal microbiota: its role in health and disease. Eur J Pediatr. 2015;174:151-167. [PMID: 25563215 DOI: 10.1007/s00431-014-2476-2] [Cited by in Crossref: 85] [Cited by in F6Publishing: 70] [Article Influence: 14.2] [Reference Citation Analysis]
57 Stolzer I, Dressel A, Chiriac MT, Neurath MF, Günther C. An IFN-STAT Axis Augments Tissue Damage and Inflammation in a Mouse Model of Crohn's Disease. Front Med (Lausanne) 2021;8:644244. [PMID: 34141714 DOI: 10.3389/fmed.2021.644244] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Lu L, Chen G, Qiu Y, Li M, Liu D, Hu D, Gu X, Xiao Z. Nanoparticle-based oral delivery systems for colon targeting: principles and design strategies. Science Bulletin 2016;61:670-81. [DOI: 10.1007/s11434-016-1056-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
59 Barreau F, Tisseyre C, Ménard S, Ferrand A, Carriere M. Titanium dioxide particles from the diet: involvement in the genesis of inflammatory bowel diseases and colorectal cancer. Part Fibre Toxicol 2021;18:26. [PMID: 34330311 DOI: 10.1186/s12989-021-00421-2] [Reference Citation Analysis]
60 Chaubey P, Momin M, Sawarkar S. Significance of Ligand-Anchored Polymers for Drug Targeting in the Treatment of Colonic Disorders. Front Pharmacol 2019;10:1628. [PMID: 32161536 DOI: 10.3389/fphar.2019.01628] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Choi EK, Aring L, Das NK, Solanki S, Inohara N, Iwase S, Samuelson LC, Shah YM, Seo YA. Impact of dietary manganese on experimental colitis in mice. FASEB J 2020;34:2929-43. [PMID: 31908045 DOI: 10.1096/fj.201902396R] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 6.5] [Reference Citation Analysis]
62 Zhang B, Wang HE, Bai YM, Tsai SJ, Su TP, Chen TJ, Wang YP, Chen MH. Inflammatory bowel disease is associated with higher dementia risk: a nationwide longitudinal study. Gut. 2020;. [PMID: 32576641 DOI: 10.1136/gutjnl-2020-320789] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 29.0] [Reference Citation Analysis]
63 Mittal R, Patel AP, Jhaveri VM, Kay SS, Debs LH, Parrish JM, Pan DR, Nguyen D, Mittal J, Jayant RD. Recent advancements in nanoparticle based drug delivery for gastrointestinal disorders. Expert Opinion on Drug Delivery 2017;15:301-18. [DOI: 10.1080/17425247.2018.1420055] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
64 Read E, Curtis MA, Neves JF. The role of oral bacteria in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2021;18:731-42. [PMID: 34400822 DOI: 10.1038/s41575-021-00488-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 李冰, 于岩波. 肠黏液屏障在肠道中的作用. 世界华人消化杂志 2017; 25(19): 1764-1771 [DOI: 10.11569/wcjd.v25.i19.1764] [Cited by in CrossRef: 1] [Article Influence: 0.3] [Reference Citation Analysis]
66 Zhao H, Yan R, Zhou X, Ji F, Zhang B. Hydrogen sulfide improves colonic barrier integrity in DSS-induced inflammation in Caco-2 cells and mice. Int Immunopharmacol 2016;39:121-7. [PMID: 27472293 DOI: 10.1016/j.intimp.2016.07.020] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
67 Engevik MA, Herrmann B, Ruan W, Engevik AC, Engevik KA, Ihekweazu F, Shi Z, Luck B, Chang-Graham AL, Esparza M, Venable S, Horvath TD, Haidacher SJ, Hoch KM, Haag AM, Schady DA, Hyser JM, Spinler JK, Versalovic J. Bifidobacterium dentium-derived y-glutamylcysteine suppresses ER-mediated goblet cell stress and reduces TNBS-driven colonic inflammation. Gut Microbes 2021;13:1-21. [PMID: 33985416 DOI: 10.1080/19490976.2021.1902717] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Bai J, jie H, wei S, Wang S, Guo H, Tang Q. GART mediates the renewal of intestinal epithelial barrier via p38/p53/PUMA cascade in colitis. Apoptosis 2016;21:1386-97. [DOI: 10.1007/s10495-016-1301-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
69 Zhang J, Tu M, Liu Z, Zhang G. Soluble epoxide hydrolase as a therapeutic target for obesity-induced disorders: roles of gut barrier function involved. Prostaglandins Leukot Essent Fatty Acids 2020;162:102180. [PMID: 33038829 DOI: 10.1016/j.plefa.2020.102180] [Reference Citation Analysis]
70 Walldorf J, Porzner M, Neumann M, Joodi G, Niess JH, von Boyen G, Mäder K, Weissbach J, Kleger A, Seufferlein T. The Selective 5-HT1A Agonist SR57746A Protects Intestinal Epithelial Cells and Enteric Glia Cells and Promotes Mucosal Recovery in Experimental Colitis. Inflamm Bowel Dis 2021:izab191. [PMID: 34417821 DOI: 10.1093/ibd/izab191] [Reference Citation Analysis]
71 Wang H, Chao K, Ng SC, Bai AH, Yu Q, Yu J, Li M, Cui Y, Chen M, Hu JF. Pro-inflammatory miR-223 mediates the cross-talk between the IL23 pathway and the intestinal barrier in inflammatory bowel disease. Genome Biol. 2016;17:58. [PMID: 27029486 DOI: 10.1186/s13059-016-0901-8] [Cited by in Crossref: 85] [Cited by in F6Publishing: 83] [Article Influence: 17.0] [Reference Citation Analysis]
72 Kondreddy V, Keshava S, Esmon CT, Pendurthi UR, Rao LVM. A critical role of endothelial cell protein C receptor in the intestinal homeostasis in experimental colitis. Sci Rep 2020;10:20569. [PMID: 33239717 DOI: 10.1038/s41598-020-77502-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Camara-Lemarroy CR, Metz L, Meddings JB, Sharkey KA, Wee Yong V. The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics. Brain. 2018;141:1900-1916. [PMID: 29860380 DOI: 10.1093/brain/awy131] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 25.0] [Reference Citation Analysis]
74 Hatayama S, Shimohata T, Amano S, Kido J, Nguyen AQ, Sato Y, Kanda Y, Tentaku A, Fukushima S, Nakahashi M, Uebanso T, Mawatari K, Takahashi A. Cellular Tight Junctions Prevent Effective Campylobacter jejuni Invasion and Inflammatory Barrier Disruption Promoting Bacterial Invasion from Lateral Membrane in Polarized Intestinal Epithelial Cells. Front Cell Infect Microbiol 2018;8:15. [PMID: 29441328 DOI: 10.3389/fcimb.2018.00015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
75 Yin HF, Yin CM, Ouyang T, Sun SD, Chen WG, Yang XL, He X, Zhang CF. Self-Nanoemulsifying Drug Delivery System of Genkwanin: A Novel Approach for Anti-Colitis-Associated Colorectal Cancer. Drug Des Devel Ther 2021;15:557-76. [PMID: 33603345 DOI: 10.2147/DDDT.S292417] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
76 Kirschman LJ, Milligan-Myhre KC. The Costs of Living Together: Immune Responses to the Microbiota and Chronic Gut Inflammation. Appl Environ Microbiol 2019;85:e02147-18. [PMID: 30530709 DOI: 10.1128/AEM.02147-18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Huang YY, Li J, Zhang HR, Bai SW, Yang HY, Shen B, Du J, Xia XM. The effect of transient receptor potential vanilloid 4 on the intestinal epithelial barrier and human colonic cells was affected by tyrosine-phosphorylated claudin-7. Biomed Pharmacother 2020;122:109697. [PMID: 31918271 DOI: 10.1016/j.biopha.2019.109697] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
78 刘海平, 姜曼, 陈朝旭, 李彦, 侯中英, 李温静, 战淑慧. 壳寡糖改善TNBS/乙醇法诱导的小鼠溃疡性结肠炎. 世界华人消化杂志 2017; 25(15): 1352-1359 [DOI: 10.11569/wcjd.v25.i15.1352] [Reference Citation Analysis]
79 Monaghan TM, Cockayne A, Mahida YR. Pathogenesis of Clostridium difficile Infection and Its Potential Role in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2015;21:1957-1966. [PMID: 26199993 DOI: 10.1097/mib.0000000000000461] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
80 Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S. Advances and Challenges of Liposome Assisted Drug Delivery. Front Pharmacol 2015;6:286. [PMID: 26648870 DOI: 10.3389/fphar.2015.00286] [Cited by in Crossref: 812] [Cited by in F6Publishing: 694] [Article Influence: 135.3] [Reference Citation Analysis]
81 Woo JK, Choi S, Kang JH, Kim DE, Hurh BS, Jeon JE, Kim SY, Oh SH. Fermented barley and soybean (BS) mixture enhances intestinal barrier function in dextran sulfate sodium (DSS)-induced colitis mouse model. BMC Complement Altern Med. 2016;16:498. [PMID: 27912750 DOI: 10.1186/s12906-016-1479-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
82 Wang K, Wu LY, Dou CZ, Guan X, Wu HG, Liu HR. Research Advance in Intestinal Mucosal Barrier and Pathogenesis of Crohn's Disease. Gastroenterol Res Pract 2016;2016:9686238. [PMID: 27651792 DOI: 10.1155/2016/9686238] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
83 von Martels JZH, Bourgonje AR, Harmsen HJM, Faber KN, Dijkstra G. Assessing intestinal permeability in Crohn's disease patients using orally administered 52Cr-EDTA. PLoS One 2019;14:e0211973. [PMID: 30730969 DOI: 10.1371/journal.pone.0211973] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
84 Xing T, Camacho Salazar R, Chen YH. Animal models for studying epithelial barriers in neonatal necrotizing enterocolitis, inflammatory bowel disease and colorectal cancer. Tissue Barriers 2017;5:e1356901. [PMID: 28795875 DOI: 10.1080/21688370.2017.1356901] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
85 Wilson NL, Vance DE, Moneyham LD, Raper JL, Mugavero MJ, Heath SL, Kempf MC. Connecting the dots: could microbial translocation explain commonly reported symptoms in HIV disease? J Assoc Nurses AIDS Care 2014;25:483-95. [PMID: 25305025 DOI: 10.1016/j.jana.2014.07.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
86 Rana T, Korolkova OY, Rachakonda G, Williams AD, Hawkins AT, James SD, Sakwe AM, Hui N, Wang L, Yu C, Goodwin JS, Izban MG, Offodile RS, Washington MK, Ballard BR, Smoot DT, Shi XZ, Forbes DS, Shanker A, M'Koma AE. Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn's colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease. PLoS One 2021;16:e0246393. [PMID: 33690604 DOI: 10.1371/journal.pone.0246393] [Reference Citation Analysis]
87 Schilrreff P, Simioni YR, Jerez HE, Caimi AT, de Farias MA, Villares Portugal R, Romero EL, Morilla MJ. Superoxide dismutase in nanoarchaeosomes for targeted delivery to inflammatory macrophages. Colloids and Surfaces B: Biointerfaces 2019;179:479-87. [DOI: 10.1016/j.colsurfb.2019.03.061] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
88 刘龚翔, 甘华田. 肠神经系统对肠上皮屏障的影响及其在炎症性肠病发生发展中的作用. 世界华人消化杂志 2017; 25(2): 107-113 [DOI: 10.11569/wcjd.v25.i2.107] [Reference Citation Analysis]
89 Li X, Lu C, Yang Y, Yu C, Rao Y. Site-specific targeted drug delivery systems for the treatment of inflammatory bowel disease. Biomed Pharmacother 2020;129:110486. [PMID: 32768972 DOI: 10.1016/j.biopha.2020.110486] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
90 魏真真, 李楠. 共聚焦激光显微内镜在溃疡性结肠炎中的研究进展. 世界华人消化杂志 2015; 23(12): 1924-1929 [DOI: 10.11569/wcjd.v23.i12.1924] [Reference Citation Analysis]
91 Li HL, Wei YY, Li XH, Zhang SS, Zhang RT, Li JH, Ma BW, Shao SB, Lv ZW, Ruan H, Zhou HG, Yang C. Diosmetin has therapeutic efficacy in colitis regulating gut microbiota, inflammation, and oxidative stress via the circ-Sirt1/Sirt1 axis. Acta Pharmacol Sin 2021. [PMID: 34262136 DOI: 10.1038/s41401-021-00726-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
92 Kim Y, de la Motte CA. The Role of Hyaluronan Treatment in Intestinal Innate Host Defense. Front Immunol 2020;11:569. [PMID: 32411124 DOI: 10.3389/fimmu.2020.00569] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
93 Sreedhar R, Arumugam S, Thandavarayan RA, Karuppagounder V, Watanabe K. Curcumin as a therapeutic agent in the chemoprevention of inflammatory bowel disease. Drug Discov Today 2016;21:843-9. [PMID: 26995272 DOI: 10.1016/j.drudis.2016.03.007] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 7.4] [Reference Citation Analysis]
94 Hua S. Advances in Oral Drug Delivery for Regional Targeting in the Gastrointestinal Tract - Influence of Physiological, Pathophysiological and Pharmaceutical Factors. Front Pharmacol 2020;11:524. [PMID: 32425781 DOI: 10.3389/fphar.2020.00524] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 21.0] [Reference Citation Analysis]
95 Tu A, Wang XC, Chen H, Jia X, Wang T, Yi Y, Liu B, Xin W, Lü X, Shan Y. Ovomucin Ameliorates Intestinal Barrier and Intestinal Bacteria to Attenuate DSS-Induced Colitis in Mice. J Agric Food Chem 2021;69:5887-96. [PMID: 34013725 DOI: 10.1021/acs.jafc.1c00865] [Reference Citation Analysis]
96 Tili E, Michaille JJ, Piurowski V, Rigot B, Croce CM. MicroRNAs in intestinal barrier function, inflammatory bowel disease and related cancers-their effects and therapeutic potentials. Curr Opin Pharmacol 2017;37:142-50. [PMID: 29154194 DOI: 10.1016/j.coph.2017.10.010] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 8.5] [Reference Citation Analysis]
97 Sicard JF, Le Bihan G, Vogeleer P, Jacques M, Harel J. Interactions of Intestinal Bacteria with Components of the Intestinal Mucus. Front Cell Infect Microbiol 2017;7:387. [PMID: 28929087 DOI: 10.3389/fcimb.2017.00387] [Cited by in Crossref: 149] [Cited by in F6Publishing: 136] [Article Influence: 37.3] [Reference Citation Analysis]
98 Benoit B, Laugerette F, Plaisancié P, Géloën A, Bodennec J, Estienne M, Pineau G, Bernalier-Donadille A, Vidal H, Michalski MC. Increasing fat content from 20 to 45 wt% in a complex diet induces lower endotoxemia in parallel with an increased number of intestinal goblet cells in mice. Nutr Res 2015;35:346-56. [PMID: 25687164 DOI: 10.1016/j.nutres.2015.01.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
99 Wan P, Peng Y, Chen G, Xie M, Dai Z, Huang K, Dong W, Zeng X, Sun Y. Dicaffeoylquinic acids from Ilex kudingcha attenuate dextran sulfate sodium-induced colitis in C57BL/6 mice in association with the modulation of gut microbiota. Journal of Functional Foods 2019;61:103468. [DOI: 10.1016/j.jff.2019.103468] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
100 Hua S, Marks E, Schneider JJ, Keely S. Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue. Nanomedicine. 2015;11:1117-1132. [PMID: 25784453 DOI: 10.1016/j.nano.2015.02.018] [Cited by in Crossref: 217] [Cited by in F6Publishing: 187] [Article Influence: 36.2] [Reference Citation Analysis]
101 Benet-Campos C, Cuéllar C, García-Ballesteros C, Zamora V, Gil-Borrás R, Catalán-Serra I, López-Chuliá F, Andreu-Ballester JC. Determination of Anti-Anisakis Simplex Antibodies and Relationship with αβ and γδ Lymphocyte Subpopulations in Patients with Crohn's Disease. Dig Dis Sci 2017;62:934-43. [PMID: 28168577 DOI: 10.1007/s10620-017-4473-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
102 Nold C, Jensen T, O'hara K, Stone J, Yellon SM, Vella AT. Replens prevents preterm birth by decreasing type I interferon strengthening the cervical epithelial barrier. Am J Reprod Immunol 2019;83. [DOI: 10.1111/aji.13192] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
103 Borisova MA, Achasova KM, Morozova KN, Andreyeva EN, Litvinova EA, Ogienko AA, Morozova MV, Berkaeva MB, Kiseleva E, Kozhevnikova EN. Mucin-2 knockout is a model of intercellular junction defects, mitochondrial damage and ATP depletion in the intestinal epithelium. Sci Rep 2020;10:21135. [PMID: 33273633 DOI: 10.1038/s41598-020-78141-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
104 Kim JE, Park JW, Kang MJ, Choi HJ, Bae SJ, Choi YS, Lee YJ, Lee HS, Hong JT, Hwang DY. Anti-Inflammatory Response and Muscarinic Cholinergic Regulation during the Laxative Effect of Asparagus cochinchinensis in Loperamide-Induced Constipation of SD Rats. Int J Mol Sci 2019;20:E946. [PMID: 30795644 DOI: 10.3390/ijms20040946] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
105 Wan P, Peng Y, Chen G, Xie M, Dai Z, Huang K, Dong W, Zeng X, Sun Y. Modulation of gut microbiota by Ilex kudingcha improves dextran sulfate sodium-induced colitis. Food Res Int. 2019;126:108595. [PMID: 31732076 DOI: 10.1016/j.foodres.2019.108595] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
106 Workman MJ, Troisi E, Targan SR, Svendsen CN, Barrett RJ. Modeling Intestinal Epithelial Response to Interferon-γ in Induced Pluripotent Stem Cell-Derived Human Intestinal Organoids. Int J Mol Sci 2020;22:E288. [PMID: 33396621 DOI: 10.3390/ijms22010288] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Park J, Choi TJ, Kang KS, Choi SH. The Interrelationships between Intestinal Permeability and Phlegm Syndrome and Therapeutic Potential of Some Medicinal Herbs. Biomolecules 2021;11:284. [PMID: 33671865 DOI: 10.3390/biom11020284] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
108 Halligan DN, Khan MN, Brown E, Rowan CR, Coulter IS, Doherty GA, Tambuwala MM, Taylor CT. Hypoxia-inducible factor hydroxylase inhibition enhances the protective effects of cyclosporine in colitis. Am J Physiol Gastrointest Liver Physiol 2019;317:G90-7. [PMID: 31070931 DOI: 10.1152/ajpgi.00049.2019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
109 Lean QY, Gueven N, Eri RD, Bhatia R, Sohal SS, Stewart N, Peterson GM, Patel RP. Heparins in ulcerative colitis: proposed mechanisms of action and potential reasons for inconsistent clinical outcomes. Expert Rev Clin Pharmacol 2015;8:795-811. [PMID: 26308504 DOI: 10.1586/17512433.2015.1082425] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
110 Michaelis L, Treß M, Löw HC, Klees J, Klameth C, Lange A, Grießhammer A, Schäfer A, Menz S, Steimle A, Schulze-Osthoff K, Frick JS. Gut Commensal-Induced IκBζ Expression in Dendritic Cells Influences the Th17 Response. Front Immunol 2020;11:612336. [PMID: 33542719 DOI: 10.3389/fimmu.2020.612336] [Reference Citation Analysis]
111 Earley H, Lennon G, Balfe A, Kilcoyne M, Clyne M, Joshi L, Carrington S, Martin ST, Coffey JC, Winter DC, O'Connell PR. A Preliminary Study Examining the Binding Capacity of Akkermansia muciniphila and Desulfovibrio spp., to Colonic Mucin in Health and Ulcerative Colitis. PLoS One 2015;10:e0135280. [PMID: 26491870 DOI: 10.1371/journal.pone.0135280] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
112 Benninghoff AD, Hintze KJ, Monsanto SP, Rodriguez DM, Hunter AH, Phatak S, Pestka JJ, Wettere AJV, Ward RE. Consumption of the Total Western Diet Promotes Colitis and Inflammation-Associated Colorectal Cancer in Mice. Nutrients 2020;12:E544. [PMID: 32093192 DOI: 10.3390/nu12020544] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
113 Fabisiak A, Murawska N, Fichna J. LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity. Pharmacol Rep 2016;68:802-8. [PMID: 27117377 DOI: 10.1016/j.pharep.2016.03.015] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 12.4] [Reference Citation Analysis]
114 Aroche R, Martínez Y, Ruan Z, Guan G, Waititu S, Nyachoti CM, Más D, Lan S. Dietary Inclusion of a Mixed Powder of Medicinal Plant Leaves Enhances the Feed Efficiency and Immune Function in Broiler Chickens. Journal of Chemistry 2018;2018:1-6. [DOI: 10.1155/2018/4073068] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
115 Wang SL, Shao BZ, Zhao SB, Fang J, Gu L, Miao CY, Li ZS, Bai Y. Impact of Paneth Cell Autophagy on Inflammatory Bowel Disease. Front Immunol 2018;9:693. [PMID: 29675025 DOI: 10.3389/fimmu.2018.00693] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
116 Lopez-Siles M, Enrich-Capó N, Aldeguer X, Sabat-Mir M, Duncan SH, Garcia-Gil LJ, Martinez-Medina M. Alterations in the Abundance and Co-occurrence of Akkermansia muciniphila and Faecalibacterium prausnitzii in the Colonic Mucosa of Inflammatory Bowel Disease Subjects. Front Cell Infect Microbiol 2018;8:281. [PMID: 30245977 DOI: 10.3389/fcimb.2018.00281] [Cited by in Crossref: 70] [Cited by in F6Publishing: 58] [Article Influence: 23.3] [Reference Citation Analysis]
117 Michielan A, D’Incà R. Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut. Mediators Inflamm. 2015;2015:628157. [PMID: 26582965 DOI: 10.1155/2015/628157] [Cited by in Crossref: 221] [Cited by in F6Publishing: 212] [Article Influence: 36.8] [Reference Citation Analysis]
118 Ballouhey Q, Fourcade L, Richard L, Bellet C, El Hamel C, Vallat JM, Sturtz F, Bourthoumieu S. Epithelial changes of congenital intestinal obstruction in a rat model. PLoS One 2020;15:e0232023. [PMID: 32352981 DOI: 10.1371/journal.pone.0232023] [Reference Citation Analysis]
119 Higa LH, Jerez HE, de Farias MA, Portugal RV, Romero EL, Morilla MJ. Ultra-small solid archaeolipid nanoparticles for active targeting to macrophages of the inflamed mucosa. Nanomedicine 2017;12:1165-75. [DOI: 10.2217/nnm-2016-0437] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
120 Salaga M, Binienda A, Draczkowski P, Kosson P, Kordek R, Jozwiak K, Fichna J. Novel peptide inhibitor of dipeptidyl peptidase IV (Tyr-Pro-D-Ala-NH2) with anti-inflammatory activity in the mouse models of colitis. Peptides 2018;108:34-45. [PMID: 30179653 DOI: 10.1016/j.peptides.2018.08.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
121 Kapitan M, Niemiec MJ, Steimle A, Frick JS, Jacobsen ID. Fungi as Part of the Microbiota and Interactions with Intestinal Bacteria. Curr Top Microbiol Immunol 2019;422:265-301. [PMID: 30062595 DOI: 10.1007/82_2018_117] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
122 Aslam MN, McClintock SD, Attili D, Pandya S, Rehman H, Nadeem DM, Jawad-Makki MAH, Rizvi AH, Berner MM, Dame MK, Turgeon DK, Varani J. Ulcerative Colitis-Derived Colonoid Culture: A Multi-Mineral-Approach to Improve Barrier Protein Expression. Front Cell Dev Biol 2020;8:577221. [PMID: 33330453 DOI: 10.3389/fcell.2020.577221] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
123 Michielan A, D’Incà R. Host-microbiome interaction in Crohn’s disease: A familiar or familial issue? World J Gastrointest Pathophysiol 2015; 6(4): 159-168 [PMID: 26600974 DOI: 10.4291/wjgp.v6.i4.159] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
124 Lean QY, Eri RD, Randall-Demllo S, Sohal SS, Stewart N, Peterson GM, Gueven N, Patel RP. Orally Administered Enoxaparin Ameliorates Acute Colitis by Reducing Macrophage-Associated Inflammatory Responses. PLoS One 2015;10:e0134259. [PMID: 26218284 DOI: 10.1371/journal.pone.0134259] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
125 Steins A, Ebbing EA, Pistorius MCM, Waasdorp C, Krishnadath KK, Medema JP, Wilmink JW, Mathôt RAA, Bijlsma MF, van Laarhoven HWM. Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxel. Drug Deliv 2017;24:1801-10. [PMID: 29172757 DOI: 10.1080/10717544.2017.1406559] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
126 Cocco M, Pellegrini C, Martínez-Banaclocha H, Giorgis M, Marini E, Costale A, Miglio G, Fornai M, Antonioli L, López-Castejón G, Tapia-Abellán A, Angosto D, Hafner-Bratkovič I, Regazzoni L, Blandizzi C, Pelegrín P, Bertinaria M. Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease. J Med Chem 2017;60:3656-71. [PMID: 28410442 DOI: 10.1021/acs.jmedchem.6b01624] [Cited by in Crossref: 69] [Cited by in F6Publishing: 71] [Article Influence: 17.3] [Reference Citation Analysis]
127 Klepsch V, Moschen AR, Tilg H, Baier G, Hermann-Kleiter N. Nuclear Receptors Regulate Intestinal Inflammation in the Context of IBD. Front Immunol 2019;10:1070. [PMID: 31139192 DOI: 10.3389/fimmu.2019.01070] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
128 Ivashkin V, Poluektov Y, Kogan E, Shifrin O, Sheptulin A, Kovaleva A, Kurbatova A, Krasnov G, Poluektova E. Disruption of the pro-inflammatory, anti-inflammatory cytokines and tight junction proteins expression, associated with changes of the composition of the gut microbiota in patients with irritable bowel syndrome. PLoS One 2021;16:e0252930. [PMID: 34115808 DOI: 10.1371/journal.pone.0252930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
129 Poyatos-Racionero E, González-Álvarez I, Sánchez-Moreno P, Sitia L, Gatto F, Pompa PP, Aznar E, González-Álvarez M, Martínez-Máñez R, Marcos MD, Bernardos A. Lactose-Gated Mesoporous Silica Particles for Intestinal Controlled Delivery of Essential Oil Components: An In Vitro and In Vivo Study. Pharmaceutics 2021;13:982. [PMID: 34209675 DOI: 10.3390/pharmaceutics13070982] [Reference Citation Analysis]
130 Ke P, Shao BZ, Xu ZQ, Chen XW, Liu C. Intestinal Autophagy and Its Pharmacological Control in Inflammatory Bowel Disease. Front Immunol 2016;7:695. [PMID: 28119697 DOI: 10.3389/fimmu.2016.00695] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
131 Zhu X, Messer JS, Wang Y, Lin F, Cham CM, Chang J, Billiar TR, Lotze MT, Boone DL, Chang EB. Cytosolic HMGB1 controls the cellular autophagy/apoptosis checkpoint during inflammation. J Clin Invest. 2015;125:1098-1110. [PMID: 25642769 DOI: 10.1172/jci76344] [Cited by in Crossref: 113] [Cited by in F6Publishing: 69] [Article Influence: 18.8] [Reference Citation Analysis]
132 Dicarlo M, Teti G, Verna G, Liso M, Cavalcanti E, Sila A, Raveenthiraraj S, Mastronardi M, Santino A, Serino G, Lippolis A, Sobolewski A, Falconi M, Chieppa M. Quercetin Exposure Suppresses the Inflammatory Pathway in Intestinal Organoids from Winnie Mice. Int J Mol Sci 2019;20:E5771. [PMID: 31744123 DOI: 10.3390/ijms20225771] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
133 Singh TP, Tehri N, Kaur G, Malik RK. Cell surface and extracellular proteins of potentially probiotic Lactobacillus reuteri as an effective mediator to regulate intestinal epithelial barrier function. Arch Microbiol 2021;203:3219-28. [PMID: 33830286 DOI: 10.1007/s00203-021-02318-2] [Reference Citation Analysis]
134 Stange EF, Schroeder BO. Microbiota and mucosal defense in IBD: an update. Expert Rev Gastroenterol Hepatol. 2019;13:963-976. [PMID: 31603356 DOI: 10.1080/17474124.2019.1671822] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 17.5] [Reference Citation Analysis]
135 Kurashima Y, Kigoshi T, Murasaki S, Arai F, Shimada K, Seki N, Kim YG, Hase K, Ohno H, Kawano K, Ashida H, Suzuki T, Morimoto M, Saito Y, Sasou A, Goda Y, Yuki Y, Inagaki Y, Iijima H, Suda W, Hattori M, Kiyono H. Pancreatic glycoprotein 2 is a first line of defense for mucosal protection in intestinal inflammation. Nat Commun 2021;12:1067. [PMID: 33594081 DOI: 10.1038/s41467-021-21277-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
136 Zeeshan M, Ali H, Khan S, Khan SA, Weigmann B. Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease. International Journal of Pharmaceutics 2019;558:201-14. [DOI: 10.1016/j.ijpharm.2018.12.074] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 16.0] [Reference Citation Analysis]
137 Paun A, Yau C, Meshkibaf S, Daigneault MC, Marandi L, Mortin-Toth S, Bar-Or A, Allen-Vercoe E, Poussier P, Danska JS. Association of HLA-dependent islet autoimmunity with systemic antibody responses to intestinal commensal bacteria in children. Sci Immunol 2019;4:eaau8125. [PMID: 30709843 DOI: 10.1126/sciimmunol.aau8125] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 19.0] [Reference Citation Analysis]
138 Deng J, Wu Z, Zhao Z, Wu C, Yuan M, Su Z, Wang Y, Wang Z. Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis. Int J Nanomedicine 2020;15:3937-51. [PMID: 32581538 DOI: 10.2147/IJN.S247406] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 11.0] [Reference Citation Analysis]
139 Kotla NG, Rana S, Sivaraman G, Sunnapu O, Vemula PK, Pandit A, Rochev Y. Bioresponsive drug delivery systems in intestinal inflammation: State-of-the-art and future perspectives. Adv Drug Deliv Rev 2019;146:248-66. [PMID: 29966684 DOI: 10.1016/j.addr.2018.06.021] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 16.3] [Reference Citation Analysis]
140 Zhang H, Wang M, Jia J, Zhao J, Radebe SM, Yu Q. The Protective Effect of E. faecium on S. typhimurium Infection Induced Damage to Intestinal Mucosa. Front Vet Sci 2021;8:740424. [PMID: 34722703 DOI: 10.3389/fvets.2021.740424] [Reference Citation Analysis]
141 Wang M, He P, Han Y, Dong L, Yun CC. Control of Intestinal Epithelial Permeability by Lysophosphatidic Acid Receptor 5. Cell Mol Gastroenterol Hepatol 2021;12:1073-92. [PMID: 33975030 DOI: 10.1016/j.jcmgh.2021.05.003] [Reference Citation Analysis]
142 Agus A, Massier S, Darfeuille-Michaud A, Billard E, Barnich N. Understanding host-adherent-invasive Escherichia coli interaction in Crohn's disease: opening up new therapeutic strategies. Biomed Res Int 2014;2014:567929. [PMID: 25580435 DOI: 10.1155/2014/567929] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 5.1] [Reference Citation Analysis]
143 Wang Y, Liu J, Huang Z, Li Y, Liang Y, Luo C, Ni C, Xie J, Su Z, Chen J, Li C. Coptisine ameliorates DSS-induced ulcerative colitis via improving intestinal barrier dysfunction and suppressing inflammatory response. Eur J Pharmacol 2021;896:173912. [PMID: 33508280 DOI: 10.1016/j.ejphar.2021.173912] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
144 Omidi-Ardali H, Lorigooini Z, Soltani A, Balali-Dehkordi S, Amini-Khoei H. Inflammatory responses bridge comorbid cardiac disorder in experimental model of IBD induced by DSS: protective effect of the trigonelline. Inflammopharmacology 2019;27:1265-73. [PMID: 30924005 DOI: 10.1007/s10787-019-00581-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
145 Gadecka A, Bielak-Zmijewska A. Slowing Down Ageing: The Role of Nutrients and Microbiota in Modulation of the Epigenome. Nutrients 2019;11:E1251. [PMID: 31159371 DOI: 10.3390/nu11061251] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
146 Serreli G, Naitza MR, Zodio S, Leoni VP, Spada M, Melis MP, Boronat A, Deiana M. Ferulic Acid Metabolites Attenuate LPS-Induced Inflammatory Response in Enterocyte-like Cells. Nutrients 2021;13:3152. [PMID: 34579029 DOI: 10.3390/nu13093152] [Reference Citation Analysis]
147 Li J, Zuo L, Tian Y, He Y, Zhang Z, Guo P, Ge Y, Hu J. Spontaneous colitis in IL-10-deficient mice was ameliorated via inhibiting glutaminase1. J Cell Mol Med 2019;23:5632-41. [PMID: 31211512 DOI: 10.1111/jcmm.14471] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
148 Lijie S, Lei S, Leilei L, Xiuxian F, Jing W, Qiang Y, Shiwei C, Jing G, Fenglin Z, Sufei H. Effect of Yang -activating and stasis-eliminating decoction from Traditional Chinese Medicine on intestinal mucosal permeability in rats with ulcerative colitis induced by dextran sulfate sodium. Journal of Traditional Chinese Medicine 2017;37:452-60. [DOI: 10.1016/s0254-6272(17)30151-6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
149 Li J, Mu Y, Liu Y, Kishimura A, Mori T, Katayama Y. Effect of Size and Loading of Retinoic Acid in Polyvinyl Butyrate Nanoparticles on Amelioration of Colitis. Polymers (Basel) 2021;13:1472. [PMID: 34063206 DOI: 10.3390/polym13091472] [Reference Citation Analysis]